Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region

Description

List of Tables

The topical drugs cdmo market global market size is expected to reach USD 125.42 billion by 2034, according to a new study by Polaris Market Research. The report "Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), By Service, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The topical drugs CDMO market refers to specialized companies that provide comprehensive services for the development, formulation, and production of pharmaceutical products designed to be applied directly to the skin or mucous membranes. These services span the entire lifecycle of a topical drug, from initial research and development to the large-scale manufacturing of commercial products. Essentially, CDMOs act as crucial partners for pharmaceutical and biopharmaceutical companies, helping them bring a wide array of topical medications to market efficiently and in compliance with strict regulatory standards.

The increasing global prevalence of various skin conditions, such as eczema, psoriasis, and acne, fuels the demand for innovative topical treatments. This, in turn, leads pharmaceutical companies to rely on CDMOs for their specialized expertise in formulating and producing complex topical medications, including mucosal drugs. Additionally, the growing trend of outsourcing within the pharmaceutical industry, driven by cost-efficiency and the need for flexible manufacturing capabilities, further boosts the demand for topical drugs CDMO services.

Topical Drugs CDMO Market Report Highlights

By formulation, the semi-solid formulations segment held the largest share in 2024 due to their widespread use across various therapeutic areas such as dermatology, pain management, and anti-infectives.

Based on service, the contract manufacturing segment dominated the market in 2024, as pharmaceutical companies increasingly outsource the actual production of their topical drugs to leverage specialized expertise, reduce operational costs, and benefit from scalable manufacturing capabilities.

By end use, the pharmaceutical companies segment held the largest share in 2024 as they consistently develop and commercialize a broad portfolio of topical drugs, from over-the-counter to prescription medications.

By region, Asia Pacific held the largest share of the topical drugs CDMO market in 2024. This is primarily attributed to cost-effectiveness in manufacturing, expanding healthcare infrastructure, and growing pharmaceutical industries in countries such as China and India, making it an attractive hub for global outsourcing of topical drug production.

A few key players in the market include The Lubrizol Corporation (Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd., Tergus Pharma, and Contract Pharmaceuticals Limited.

Polaris Market Research has segmented the topical drugs CDMO market report based on formulation, service, end use, and region:

By Formulation Outlook (Revenue - USD Billion, 2020-2034)

Semi-solid Formulations

Creams

Ointments

Gel

Others

Liquid Formulations

Solid Formulations

Transdermal Products

By Service Outlook (Revenue - USD Billion, 2020-2034)

Contract Development

Contract Manufacturing

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Pharmaceutical Companies

Biopharmaceutical Companies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5770

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Topical Drugs CDMO Market Insights

4.1. Topical Drugs CDMO Market - Market Snapshot
4.2. Topical Drugs CDMO Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Skin Conditions
  - 4.2.1.2. Growing Trend of Pharmaceutical Outsourcing
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory Complexity and Stringency
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Topical Drugs CDMO Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Topical Drugs CDMO Market, by Formulation

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
5.3. Semi-solid Formulations
- 5.3.1. Global Topical Drugs CDMO Market, by Semi-solid Formulations, by Region, 2020-2034 (USD Billion)
5.4. Liquid Formulations
- 5.4.1. Global Topical Drugs CDMO Market, by Liquid Formulations, by Region, 2020-2034 (USD Billion)
5.5. Solid Formulations
- 5.5.1. Global Topical Drugs CDMO Market, by Solid Formulations, by Region, 2020-2034 (USD Billion)
5.6. Transdermal Products
- 5.6.1. Global Topical Drugs CDMO Market, by Transdermal Products, by Region, 2020-2034 (USD Billion)

6. Global Topical Drugs CDMO Market, by Service

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
6.3. Contract Development
- 6.3.1. Global Topical Drugs CDMO Market, by Contract Development, by Region, 2020-2034 (USD Billion)
6.4. Contract Manufacturing
- 6.4.1. Global Topical Drugs CDMO Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

7. Global Topical Drugs CDMO Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
7.3. Pharmaceutical Companies
- 7.3.1. Global Topical Drugs CDMO Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.4. Biopharmaceutical Companies
- 7.4.1. Global Topical Drugs CDMO Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Topical Drugs CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Topical Drugs CDMO Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Topical Drugs CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Topical Drugs CDMO Market - North America
- 8.3.1. North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.2. North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.3.3. North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Topical Drugs CDMO Market - U.S.
  - 8.3.4.1. U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Topical Drugs CDMO Market - Canada
  - 8.3.5.1. Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.4. Topical Drugs CDMO Market - Europe
- 8.4.1. Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.2. Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.3. Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Topical Drugs CDMO Market - UK
  - 8.4.4.1. UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Topical Drugs CDMO Market - France
  - 8.4.5.1. France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Topical Drugs CDMO Market - Germany
  - 8.4.6.1. Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Topical Drugs CDMO Market - Italy
  - 8.4.7.1. Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Topical Drugs CDMO Market - Spain
  - 8.4.8.1. Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Topical Drugs CDMO Market - Netherlands
  - 8.4.9.1. Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Topical Drugs CDMO Market - Russia
  - 8.4.10.1. Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Topical Drugs CDMO Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.5. Topical Drugs CDMO Market - Asia Pacific
- 8.5.1. Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Topical Drugs CDMO Market - China
  - 8.5.4.1. China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Topical Drugs CDMO Market - India
  - 8.5.5.1. India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Topical Drugs CDMO Market - Malaysia
  - 8.5.6.1. Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Topical Drugs CDMO Market - Japan
  - 8.5.7.1. Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Topical Drugs CDMO Market - Indonesia
  - 8.5.8.1. Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Topical Drugs CDMO Market - South Korea
  - 8.5.9.1. South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Topical Drugs CDMO Market - Australia
  - 8.5.10.1. Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Topical Drugs CDMO Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.6. Topical Drugs CDMO Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Topical Drugs CDMO Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Topical Drugs CDMO Market - UAE
  - 8.6.5.1. UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Topical Drugs CDMO Market - Israel
  - 8.6.6.1. Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Topical Drugs CDMO Market - South Africa
  - 8.6.7.1. South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Topical Drugs CDMO Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.7. Topical Drugs CDMO Market - Latin America
- 8.7.1. Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Topical Drugs CDMO Market - Mexico
  - 8.7.4.1. Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Topical Drugs CDMO Market - Brazil
  - 8.7.5.1. Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Topical Drugs CDMO Market - Argentina
  - 8.7.6.1. Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Topical Drugs CDMO Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Cambrex Corporation
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Catalent Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Contract Pharmaceuticals Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. MedPharm Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. PCI Pharma Services
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Pierre Fabre S.A.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Piramal Pharma Solutions
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Recipharm AB
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Tergus Pharma
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. The Lubrizol Corporation (Lubrizol Life Science)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development